- Home
- CMBM vs LSTA Comparison
CMBM vs LSTA Comparison
Compare CMBM & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- LSTA
- Stock Information
- Founded
- CMBM 2011
- LSTA 1980
- Country
- CMBM United States
- LSTA United States
- Employees
- CMBM N/A
- LSTA N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- LSTA Misc Health and Biotechnology Services
- Sector
- CMBM Technology
- LSTA Health Care
- Exchange
- CMBM Nasdaq
- LSTA Nasdaq
- Market Cap
- CMBM 12.1M
- LSTA 20.0M
- IPO Year
- CMBM 2019
- LSTA N/A
- Fundamental
- Price
- CMBM $0.45
- LSTA $2.37
- Analyst Decision
- CMBM Strong Buy
- LSTA Strong Buy
- Analyst Count
- CMBM 2
- LSTA 1
- Target Price
- CMBM $5.50
- LSTA $15.00
- AVG Volume (30 Days)
- CMBM 140.5K
- LSTA 9.6K
- Earning Date
- CMBM 05-16-2025
- LSTA 05-08-2025
- Dividend Yield
- CMBM N/A
- LSTA N/A
- EPS Growth
- CMBM N/A
- LSTA N/A
- EPS
- CMBM N/A
- LSTA N/A
- Revenue
- CMBM $172,215,000.00
- LSTA $1,000,000.00
- Revenue This Year
- CMBM N/A
- LSTA N/A
- Revenue Next Year
- CMBM $17.13
- LSTA N/A
- P/E Ratio
- CMBM N/A
- LSTA N/A
- Revenue Growth
- CMBM N/A
- LSTA N/A
- 52 Week Low
- CMBM $0.23
- LSTA $1.87
- 52 Week High
- CMBM $4.16
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CMBM 47.95
- LSTA 53.86
- Support Level
- CMBM $0.42
- LSTA $2.30
- Resistance Level
- CMBM $0.41
- LSTA $2.55
- Average True Range (ATR)
- CMBM 0.03
- LSTA 0.15
- MACD
- CMBM 0.02
- LSTA 0.00
- Stochastic Oscillator
- CMBM 72.70
- LSTA 58.31
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.